ArticleCanadian journal of kidney health and disease2026
Emergency Department Utilization after Initiation of Intermittent Hemodialysis: A Retrospective Cohort Study in Regina, Saskatchewan.
Article in Canadian journal of kidney health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Emergency department (ED) use is common among patients with end-stage kidney disease (ESKD) initiating hemodialysis (HD), but potentially modifiable predictors of these visits remain poorly defined. Objective: To identify factors associated with ED visits among patients newly initiated on intermittent HD in Regina, Saskatchewan, Canada. Design: Retrospective cohort study. Setting: Regina General Hospital in Saskatchewan, Canada. Patients: 360 incident adult patients who received at least 90 days of HD between January 1, 2018, and December 31, 2022. Measurements: Patients were followed for one year from dialysis initiation to capture the number and causes of all-cause ED visits. Methods: Multinomial logistic regression was used to examine associations between patient characteristics and ED utilization, categorized as no visits, a single visit, 2-3 visits, or >3 visits, with no visits as the reference group. Results: Half of the cohort (n=180, 50%) had at least one ED visit during the first year, totaling 453 encounters. Gastrointestinal (GI) complaints were the most common reason for presentation (14.1%), followed by fluid overload (11.5%) and cardiovascular causes (8.3%). Dialysis non-adherence was independently associated with ED utilization across all categories, with the strongest association for >3 visits (RRR 7.34, 95% CI 2.81-19.20, p<0.001). Arteriovenous fistula use at dialysis initiation was associated with a lower risk of a single ED visit (RRR 0.28, 95% CI 0.09-0.90, p=0.033). In contrast, age, sex, diabetes, hypertension, and cardiovascular disease were not independently associated with ED utilization. Limitations: This single-center, retrospective study is limited by generalizability and could not analyze non-adherence factors. ED visits were grouped broadly, without assessing severity or preventability. Although ED visits were more frequent during the winter months, we did not examine whether missed dialysis treatments also varied by season. The study period from 2018 to 2022 overlaps with the COVID-19 pandemic, which may have affected ED utilization, dialysis attendance, outpatient access, and patient health-seeking behavior. This limits direct comparison with studies conducted entirely before or after the pandemic. Conclusions: Early ED utilization among incident HD patients may be reduced by improving dialysis adherence, ensuring timely permanent vascular access placement, and better management of GI symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.